1.0.0.3falseFinancial Instruments and Derivativesfalse1$falsefalseiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0sharesStandardhttp://www.xbrl.org/2003/instanceshares053us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlockus-gaaptruenadurationstringNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalse00<div>
<p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>12. Financial
Instruments and Derivatives</b></font></p>
<p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">The fair value of financial
instruments is determined by reference to various market data and
other valuation techniques as appropriate. The estimated fair value
of total long-term debt, including capitalized lease obligations,
at December 31, 2009, and 2008, was $7.7 billion and $7.6
billion, respectively, as compared to recorded book values of $7.1
billion and $7.0 billion. The fair value hierarchy for long-term
debt is primarily Level 2 (observable input).</font></p>
<p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px">
<font style="FONT-FAMILY: Times New Roman" size="2">The
Corporation’s size, strong capital structure, geographic
diversity and the complementary nature of the Upstream, Downstream
and Chemical businesses reduce the Corporation’s
enterprise-wide risk from changes in interest rates, currency rates
and commodity prices. As a result, the Corporation makes limited
use of derivatives to mitigate the impact of such changes. The
Corporation does not engage in speculative derivative activities or
derivative trading activities nor does it use derivatives with
leveraged features. The Corporation maintains a system of controls
that includes the authorization, reporting and monitoring of
derivative activity. The Corporation’s limited derivative
activities pose no material credit or market risks to
ExxonMobil’s operations, financial condition or
liquidity.</font></p>
<p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px">
<font style="FONT-FAMILY: Times New Roman" size="2">The estimated
fair value of derivatives outstanding and recorded on the balance
sheet was a net payable of $5 million at year-end 2009 and a net
receivable of $118 million at year-end 2008. This is the amount
that the Corporation would have paid to, or received from, third
parties if these derivatives had been settled in the open market.
The Corporation recognized a before-tax loss of $60 million and a
before-tax gain of $89 million and $66 million related to
derivatives during 2009, 2008 and 2007, respectively.</font></p>
<p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px">
<font style="FONT-FAMILY: Times New Roman" size="2">The fair value
of derivatives outstanding at year-end 2009 and loss recognized
during the year are immaterial in relation to the
Corporation’s year-end cash balance of $10.7 billion, total
assets of $233.3 billion or net income for the year of $19.3
billion.</font></p>
</div>12. Financial
Instruments and Derivatives
The fair value of financial
instruments is determined by reference to various market data and
other valuationfalsefalseNo definition available.No authoritative reference available.falsefalse11falseUnKnownUnKnownUnKnownfalsetrue